What is Imprivata exploring?

Imprivata, a digital identity software provider for the healthcare industry, is exploring a sale.

What is the potential valuation for Imprivata's sale?

The sale of Imprivata could value the company at up to $7 billion or potentially more.

When did Thoma Bravo acquire Imprivata?

Thoma Bravo acquired Imprivata in 2016 in a take-private transaction valued at $544 million.

Home / Business and Economy / Thoma Bravo Eyes $7B Sale of Imprivata

Thoma Bravo Eyes $7B Sale of Imprivata

31 Jan

•

Summary

Imprivata, a healthcare digital identity provider, is exploring a sale.
The sale could value the company at up to $7 billion.
Thoma Bravo acquired Imprivata in 2016 for $544 million.

Thoma Bravo, a private equity firm specializing in software investments, is reportedly exploring the sale of Imprivata, a company focused on digital identity solutions for the healthcare sector. Investment bankers from JPMorgan and Evercore are assisting in the early stages of this sale process.

Sources indicate that Imprivata could be valued at approximately $7 billion or more, representing a substantial return for Thoma Bravo, which initially acquired the company in 2016 for $544 million. The cybersecurity firm has expanded its operations through various acquisitions since then.

Imprivata, based in Waltham, Massachusetts, provides crucial identity and access management software, enabling healthcare workers to securely access clinical systems and sensitive data. The company is recognized as a leader in healthcare security and is generating around $500 million in revenue while experiencing rapid growth.